At Elite Primary Care Group, our experienced providers will work closely with you to select the most appropriate treatment, monitor your progress, and offer ongoing support to maximize your results
Evaluation of novel TGR5 agonist in combination with Sitagliptin for possible treatment of type 2 diabetes
Anti-Aging and Skin Rejuvenating Properties: Glutathione fights free radicals, reduces oxidative stress, and slows aging
The EMAs review, launched in December 2024, found that the risk of developing NAION more than doubled in patients taking semaglutide compared to those on other diabetes medications, with an estimated frequency of up to 1 in 10,000
Retatrutide is a synthetic peptide investigated as a simultaneous agonist of the GIP (glucose-dependent insulinotropic polypeptide), GLP-1 (glucagon-like peptide-1), and glucagon receptors